Search results

This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.

The Graduate Institute is part of ANSTO’s Innovation Precinct and links all graduates together to create a network of Australia’s brightest young minds focused on the future.

With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.

Griffith University researchers are conducting an experiment at ANSTO that will test a revolutionary physics theory that time reversal symmetry-breaking by neutrinos might cause a time dilation at the quantum scale.

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

ANSTO provides a summary of water usage and discharge for FY2024 - FY2025

The release of the Oppenheimer film, the story of the director of the Manhattan Project,  has prompted many people to go online and search for an explanation of the difference between fission and fusion, two fundamental scientific concepts.

ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.

Year 11 STEM student and aspiring physicist was given the opportunity of a lifetime to tour ANSTO’s Lucas Heights campus and meet some of Australia’s top researchers.

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.